Latest News for: pat roe

Edit

I-Sec initiates coverage on Suven Pharmaceuticals with a Buy rating, target price Rs 1,400

The Times of India 27 Mar 2025
... of improving RoE and substantial free cash flow generation.
Edit

Active Infrastructures IPO opens on March 21 | Price band & all details

Hindustan Times 19 Mar 2025
Also read. Google buys Wiz ... Report ... For FY23-24 ended March 2024, company has reported net profit of ₹10.45 crore and revenue of ₹97.43 crore with a strong return ratios including ROE at 36.22%, ROCE at 14.90%, RONW at 36.22% and PAT margin of 10.75%.
  • 1
×